Testing a drug for severe fatigue in lupus patients
Treatments studied
Part of Immune system & allergy, Skin clinical trials.
This study tests if a drug called anifrolumab can reduce severe fatigue in people with lupus. It is for adults whose lupus is under control but still feel very tired most days.
Summary written for real people, not researchers, by Clin2.
Who can take part
- 18 to 64 years old
- Diagnosed with lupus according to the American College of Rheumatology criteria
- Had severe fatigue for at least 3 months (score of 6 or higher on a 0-10 scale)
- Your lupus activity is low and stable
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a new drug called anifrolumab can help treat lupus in people who haven't taken strong medications like biologics or immunosuppressants before. It looks at overall disease activity and the chance to reduce steroid use.
This trial tests anifrolumab, given as a shot under the skin or through a vein, to see how it works in people with lupus. It may help if you have active lupus symptoms and are on standard treatments.
This study tests anifrolumab, a new injection medicine that may help control systemic lupus erythematosus (SLE) in children and teens. Researchers will measure how the body processes the medicine and whether it helps reduce lupus activity while monitoring for side effects.
This study tracks how well anifrolumab works and how safe it is for people with active lupus. It's a real-world look at the drug's effects, so no additional treatments or tests are required beyond what your doctor already prescribes.
This study looks at potential risks of the lupus medication anifrolumab in people with moderate to severe SLE. It focuses on serious infections and malignancies to see how safe the treatment is.
This trial tests whether a drug called anifrolumab can improve early signs of heart and blood vessel damage in people with lupus. It may help prevent future heart problems and strokes.
Hear when a new Systemic Lupus Erythematosus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.